Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol, Ketoconazole, and Hydrocortisone in Androgen Independent Prostate Cancer
NCT00536991Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Oct 2006
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of calcitriol in prostate adenocarcinoma, sponsored by Roswell Park Comprehensive Cancer Center. Started Oct 2006; status: terminated.
02
Drugs
calcitriol
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT00536991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00536991.